nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—SCN5A—Riluzole—amyotrophic lateral sclerosis	0.534	1	CbGbCtD
Zonisamide—SCN3A—spinal nerve—amyotrophic lateral sclerosis	0.00888	0.0534	CbGeAlD
Zonisamide—Pneumonia aspiration—Riluzole—amyotrophic lateral sclerosis	0.0082	0.0343	CcSEcCtD
Zonisamide—Facial paralysis—Riluzole—amyotrophic lateral sclerosis	0.00563	0.0235	CcSEcCtD
Zonisamide—Circumoral paresthesia—Riluzole—amyotrophic lateral sclerosis	0.00549	0.023	CcSEcCtD
Zonisamide—CA13—nerve—amyotrophic lateral sclerosis	0.00541	0.0325	CbGeAlD
Zonisamide—CA13—tongue—amyotrophic lateral sclerosis	0.00528	0.0318	CbGeAlD
Zonisamide—CA10—hindbrain—amyotrophic lateral sclerosis	0.00482	0.029	CbGeAlD
Zonisamide—SCN11A—peripheral nervous system—amyotrophic lateral sclerosis	0.00475	0.0286	CbGeAlD
Zonisamide—CA8—hindbrain—amyotrophic lateral sclerosis	0.00473	0.0285	CbGeAlD
Zonisamide—VIIth nerve paralysis—Riluzole—amyotrophic lateral sclerosis	0.00436	0.0182	CcSEcCtD
Zonisamide—CNS depression NOS—Riluzole—amyotrophic lateral sclerosis	0.00436	0.0182	CcSEcCtD
Zonisamide—CA13—hindbrain—amyotrophic lateral sclerosis	0.00405	0.0244	CbGeAlD
Zonisamide—Paraesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.00382	0.016	CcSEcCtD
Zonisamide—SCN11A—nerve—amyotrophic lateral sclerosis	0.0037	0.0223	CbGeAlD
Zonisamide—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.0036	0.015	CcSEcCtD
Zonisamide—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.00355	0.0148	CcSEcCtD
Zonisamide—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.00341	0.0142	CcSEcCtD
Zonisamide—CA11—hindbrain—amyotrophic lateral sclerosis	0.0034	0.0205	CbGeAlD
Zonisamide—Urine abnormality—Riluzole—amyotrophic lateral sclerosis	0.00323	0.0135	CcSEcCtD
Zonisamide—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.00316	0.0132	CcSEcCtD
Zonisamide—Micturition urgency—Riluzole—amyotrophic lateral sclerosis	0.00316	0.0132	CcSEcCtD
Zonisamide—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.00316	0.0132	CcSEcCtD
Zonisamide—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.00312	0.013	CcSEcCtD
Zonisamide—Urine analysis abnormal—Riluzole—amyotrophic lateral sclerosis	0.00304	0.0127	CcSEcCtD
Zonisamide—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.00298	0.0124	CcSEcCtD
Zonisamide—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.00285	0.0119	CcSEcCtD
Zonisamide—CA10—brainstem—amyotrophic lateral sclerosis	0.00277	0.0166	CbGeAlD
Zonisamide—CA8—brainstem—amyotrophic lateral sclerosis	0.00271	0.0163	CbGeAlD
Zonisamide—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00265	0.0111	CcSEcCtD
Zonisamide—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.0026	0.0109	CcSEcCtD
Zonisamide—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.00258	0.0108	CcSEcCtD
Zonisamide—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.00242	0.0101	CcSEcCtD
Zonisamide—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.0024	0.01	CcSEcCtD
Zonisamide—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00994	CcSEcCtD
Zonisamide—CA13—brainstem—amyotrophic lateral sclerosis	0.00232	0.014	CbGeAlD
Zonisamide—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00969	CcSEcCtD
Zonisamide—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00223	0.00931	CcSEcCtD
Zonisamide—SCN2B—medulla oblongata—amyotrophic lateral sclerosis	0.00222	0.0134	CbGeAlD
Zonisamide—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00218	0.0091	CcSEcCtD
Zonisamide—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00889	CcSEcCtD
Zonisamide—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00211	0.00883	CcSEcCtD
Zonisamide—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00204	0.00852	CcSEcCtD
Zonisamide—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00846	CcSEcCtD
Zonisamide—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.002	0.00834	CcSEcCtD
Zonisamide—SCN2B—spinal cord—amyotrophic lateral sclerosis	0.00198	0.0119	CbGeAlD
Zonisamide—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00828	CcSEcCtD
Zonisamide—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00817	CcSEcCtD
Zonisamide—CA11—brainstem—amyotrophic lateral sclerosis	0.00195	0.0117	CbGeAlD
Zonisamide—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00812	CcSEcCtD
Zonisamide—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00193	0.00807	CcSEcCtD
Zonisamide—CA10—medulla oblongata—amyotrophic lateral sclerosis	0.00193	0.0116	CbGeAlD
Zonisamide—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00796	CcSEcCtD
Zonisamide—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00791	CcSEcCtD
Zonisamide—SCN3B—medulla oblongata—amyotrophic lateral sclerosis	0.00186	0.0112	CbGeAlD
Zonisamide—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00767	CcSEcCtD
Zonisamide—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00182	0.00762	CcSEcCtD
Zonisamide—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00748	CcSEcCtD
Zonisamide—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00748	CcSEcCtD
Zonisamide—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00739	CcSEcCtD
Zonisamide—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00731	CcSEcCtD
Zonisamide—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00723	CcSEcCtD
Zonisamide—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00723	CcSEcCtD
Zonisamide—CA10—spinal cord—amyotrophic lateral sclerosis	0.00172	0.0103	CbGeAlD
Zonisamide—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00703	CcSEcCtD
Zonisamide—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00703	CcSEcCtD
Zonisamide—SCN2B—nervous system—amyotrophic lateral sclerosis	0.00167	0.0101	CbGeAlD
Zonisamide—SCN3B—spinal cord—amyotrophic lateral sclerosis	0.00166	0.00996	CbGeAlD
Zonisamide—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00687	CcSEcCtD
Zonisamide—Coma—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00684	CcSEcCtD
Zonisamide—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00677	CcSEcCtD
Zonisamide—SCN2B—central nervous system—amyotrophic lateral sclerosis	0.00161	0.00968	CbGeAlD
Zonisamide—SCN1A—hindbrain—amyotrophic lateral sclerosis	0.00159	0.00955	CbGeAlD
Zonisamide—SCN4B—medulla oblongata—amyotrophic lateral sclerosis	0.00158	0.0095	CbGeAlD
Zonisamide—SCN2B—cerebellum—amyotrophic lateral sclerosis	0.00157	0.00946	CbGeAlD
Zonisamide—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00656	CcSEcCtD
Zonisamide—CA1—nerve—amyotrophic lateral sclerosis	0.00155	0.00935	CbGeAlD
Zonisamide—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00643	CcSEcCtD
Zonisamide—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00637	CcSEcCtD
Zonisamide—SCN1B—nervous system—amyotrophic lateral sclerosis	0.00151	0.00909	CbGeAlD
Zonisamide—SCN2A—hindbrain—amyotrophic lateral sclerosis	0.00146	0.00877	CbGeAlD
Zonisamide—SCN1B—central nervous system—amyotrophic lateral sclerosis	0.00145	0.00876	CbGeAlD
Zonisamide—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00607	CcSEcCtD
Zonisamide—CA10—nervous system—amyotrophic lateral sclerosis	0.00145	0.00872	CbGeAlD
Zonisamide—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00604	CcSEcCtD
Zonisamide—SCN1B—cerebellum—amyotrophic lateral sclerosis	0.00142	0.00856	CbGeAlD
Zonisamide—CA8—nervous system—amyotrophic lateral sclerosis	0.00142	0.00855	CbGeAlD
Zonisamide—Injury—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00591	CcSEcCtD
Zonisamide—SCN4B—spinal cord—amyotrophic lateral sclerosis	0.00141	0.00847	CbGeAlD
Zonisamide—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00586	CcSEcCtD
Zonisamide—CA10—central nervous system—amyotrophic lateral sclerosis	0.00139	0.00839	CbGeAlD
Zonisamide—SCN3B—nervous system—amyotrophic lateral sclerosis	0.00139	0.00839	CbGeAlD
Zonisamide—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00578	CcSEcCtD
Zonisamide—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00573	CcSEcCtD
Zonisamide—CA8—central nervous system—amyotrophic lateral sclerosis	0.00137	0.00823	CbGeAlD
Zonisamide—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00571	CcSEcCtD
Zonisamide—CA10—cerebellum—amyotrophic lateral sclerosis	0.00136	0.0082	CbGeAlD
Zonisamide—CA11—medulla oblongata—amyotrophic lateral sclerosis	0.00136	0.00818	CbGeAlD
Zonisamide—SCN3B—central nervous system—amyotrophic lateral sclerosis	0.00134	0.00808	CbGeAlD
Zonisamide—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00559	CcSEcCtD
Zonisamide—CA8—cerebellum—amyotrophic lateral sclerosis	0.00134	0.00805	CbGeAlD
Zonisamide—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00557	CcSEcCtD
Zonisamide—SCN3B—cerebellum—amyotrophic lateral sclerosis	0.00131	0.0079	CbGeAlD
Zonisamide—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00545	CcSEcCtD
Zonisamide—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00543	CcSEcCtD
Zonisamide—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00543	CcSEcCtD
Zonisamide—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00539	CcSEcCtD
Zonisamide—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00535	CcSEcCtD
Zonisamide—SCN2B—brain—amyotrophic lateral sclerosis	0.00128	0.00769	CbGeAlD
Zonisamide—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00127	0.0053	CcSEcCtD
Zonisamide—MAOB—nerve—amyotrophic lateral sclerosis	0.00126	0.00759	CbGeAlD
Zonisamide—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00524	CcSEcCtD
Zonisamide—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00516	CcSEcCtD
Zonisamide—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00515	CcSEcCtD
Zonisamide—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00511	CcSEcCtD
Zonisamide—CA13—nervous system—amyotrophic lateral sclerosis	0.00122	0.00732	CbGeAlD
Zonisamide—CA4—nerve—amyotrophic lateral sclerosis	0.00121	0.00731	CbGeAlD
Zonisamide—CA11—spinal cord—amyotrophic lateral sclerosis	0.00121	0.00729	CbGeAlD
Zonisamide—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00505	CcSEcCtD
Zonisamide—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00501	CcSEcCtD
Zonisamide—SCN4B—nervous system—amyotrophic lateral sclerosis	0.00119	0.00714	CbGeAlD
Zonisamide—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00494	CcSEcCtD
Zonisamide—CA13—central nervous system—amyotrophic lateral sclerosis	0.00117	0.00704	CbGeAlD
Zonisamide—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00489	CcSEcCtD
Zonisamide—SCN1B—brain—amyotrophic lateral sclerosis	0.00116	0.00695	CbGeAlD
Zonisamide—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00481	CcSEcCtD
Zonisamide—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00479	CcSEcCtD
Zonisamide—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00479	CcSEcCtD
Zonisamide—CA13—cerebellum—amyotrophic lateral sclerosis	0.00114	0.00689	CbGeAlD
Zonisamide—SCN4B—central nervous system—amyotrophic lateral sclerosis	0.00114	0.00687	CbGeAlD
Zonisamide—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00469	CcSEcCtD
Zonisamide—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00469	CcSEcCtD
Zonisamide—SCN4B—cerebellum—amyotrophic lateral sclerosis	0.00112	0.00672	CbGeAlD
Zonisamide—CA10—brain—amyotrophic lateral sclerosis	0.00111	0.00666	CbGeAlD
Zonisamide—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.0011	0.0046	CcSEcCtD
Zonisamide—CACNA1I—cerebellum—amyotrophic lateral sclerosis	0.00109	0.00656	CbGeAlD
Zonisamide—CA8—brain—amyotrophic lateral sclerosis	0.00109	0.00654	CbGeAlD
Zonisamide—MAOA—nerve—amyotrophic lateral sclerosis	0.00108	0.00647	CbGeAlD
Zonisamide—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00446	CcSEcCtD
Zonisamide—SCN3B—brain—amyotrophic lateral sclerosis	0.00107	0.00642	CbGeAlD
Zonisamide—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00439	CcSEcCtD
Zonisamide—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00434	CcSEcCtD
Zonisamide—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00432	CcSEcCtD
Zonisamide—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00427	CcSEcCtD
Zonisamide—CA11—nervous system—amyotrophic lateral sclerosis	0.00102	0.00614	CbGeAlD
Zonisamide—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00425	CcSEcCtD
Zonisamide—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00421	CcSEcCtD
Zonisamide—Depression—Riluzole—amyotrophic lateral sclerosis	0.000999	0.00417	CcSEcCtD
Zonisamide—SCN11A—spinal cord—amyotrophic lateral sclerosis	0.000988	0.00594	CbGeAlD
Zonisamide—CA11—central nervous system—amyotrophic lateral sclerosis	0.000983	0.00591	CbGeAlD
Zonisamide—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.000982	0.0041	CcSEcCtD
Zonisamide—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.000976	0.00408	CcSEcCtD
Zonisamide—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.000973	0.00407	CcSEcCtD
Zonisamide—CA11—cerebellum—amyotrophic lateral sclerosis	0.000961	0.00578	CbGeAlD
Zonisamide—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00096	0.00401	CcSEcCtD
Zonisamide—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.000955	0.00399	CcSEcCtD
Zonisamide—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.000947	0.00396	CcSEcCtD
Zonisamide—MAOB—hindbrain—amyotrophic lateral sclerosis	0.000944	0.00568	CbGeAlD
Zonisamide—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.000935	0.00391	CcSEcCtD
Zonisamide—CA13—brain—amyotrophic lateral sclerosis	0.000929	0.00559	CbGeAlD
Zonisamide—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.000915	0.00383	CcSEcCtD
Zonisamide—SCN1A—brainstem—amyotrophic lateral sclerosis	0.00091	0.00548	CbGeAlD
Zonisamide—CA4—hindbrain—amyotrophic lateral sclerosis	0.00091	0.00547	CbGeAlD
Zonisamide—SCN4B—brain—amyotrophic lateral sclerosis	0.000906	0.00545	CbGeAlD
Zonisamide—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.000901	0.00377	CcSEcCtD
Zonisamide—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.000895	0.00374	CcSEcCtD
Zonisamide—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.000892	0.00373	CcSEcCtD
Zonisamide—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.000888	0.00371	CcSEcCtD
Zonisamide—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000886	0.0037	CcSEcCtD
Zonisamide—CACNA1I—brain—amyotrophic lateral sclerosis	0.000885	0.00533	CbGeAlD
Zonisamide—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.000883	0.00369	CcSEcCtD
Zonisamide—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.000881	0.00368	CcSEcCtD
Zonisamide—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00085	0.00355	CcSEcCtD
Zonisamide—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00084	0.00351	CcSEcCtD
Zonisamide—SCN2A—brainstem—amyotrophic lateral sclerosis	0.000835	0.00503	CbGeAlD
Zonisamide—SCN11A—nervous system—amyotrophic lateral sclerosis	0.000832	0.00501	CbGeAlD
Zonisamide—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.000812	0.00339	CcSEcCtD
Zonisamide—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00081	0.00339	CcSEcCtD
Zonisamide—MAOA—hindbrain—amyotrophic lateral sclerosis	0.000806	0.00485	CbGeAlD
Zonisamide—SCN11A—central nervous system—amyotrophic lateral sclerosis	0.000801	0.00482	CbGeAlD
Zonisamide—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000794	0.00332	CcSEcCtD
Zonisamide—CACNA1G—nervous system—amyotrophic lateral sclerosis	0.000794	0.00478	CbGeAlD
Zonisamide—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000788	0.00329	CcSEcCtD
Zonisamide—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.000783	0.00327	CcSEcCtD
Zonisamide—CA11—brain—amyotrophic lateral sclerosis	0.00078	0.0047	CbGeAlD
Zonisamide—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.000771	0.00322	CcSEcCtD
Zonisamide—Tension—Riluzole—amyotrophic lateral sclerosis	0.000768	0.00321	CcSEcCtD
Zonisamide—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000766	0.0032	CcSEcCtD
Zonisamide—CACNA1G—central nervous system—amyotrophic lateral sclerosis	0.000764	0.0046	CbGeAlD
Zonisamide—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00076	0.00318	CcSEcCtD
Zonisamide—CA2—hindbrain—amyotrophic lateral sclerosis	0.000754	0.00454	CbGeAlD
Zonisamide—CA14—medulla oblongata—amyotrophic lateral sclerosis	0.000753	0.00453	CbGeAlD
Zonisamide—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000752	0.00314	CcSEcCtD
Zonisamide—CACNA1G—cerebellum—amyotrophic lateral sclerosis	0.000747	0.0045	CbGeAlD
Zonisamide—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000733	0.00306	CcSEcCtD
Zonisamide—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000726	0.00304	CcSEcCtD
Zonisamide—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000723	0.00302	CcSEcCtD
Zonisamide—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000719	0.00301	CcSEcCtD
Zonisamide—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000706	0.00295	CcSEcCtD
Zonisamide—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000703	0.00294	CcSEcCtD
Zonisamide—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000702	0.00293	CcSEcCtD
Zonisamide—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000701	0.00293	CcSEcCtD
Zonisamide—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000692	0.00289	CcSEcCtD
Zonisamide—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000688	0.00288	CcSEcCtD
Zonisamide—Cough—Riluzole—amyotrophic lateral sclerosis	0.000683	0.00285	CcSEcCtD
Zonisamide—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000678	0.00283	CcSEcCtD
Zonisamide—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000676	0.00282	CcSEcCtD
Zonisamide—CA14—spinal cord—amyotrophic lateral sclerosis	0.000671	0.00404	CbGeAlD
Zonisamide—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000666	0.00278	CcSEcCtD
Zonisamide—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000666	0.00278	CcSEcCtD
Zonisamide—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000666	0.00278	CcSEcCtD
Zonisamide—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000664	0.00278	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000662	0.00277	CcSEcCtD
Zonisamide—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000658	0.00275	CcSEcCtD
Zonisamide—SCN9A—spinal cord—amyotrophic lateral sclerosis	0.000658	0.00396	CbGeAlD
Zonisamide—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000652	0.00272	CcSEcCtD
Zonisamide—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000644	0.00269	CcSEcCtD
Zonisamide—CA7—cerebellum—amyotrophic lateral sclerosis	0.000639	0.00385	CbGeAlD
Zonisamide—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000639	0.00267	CcSEcCtD
Zonisamide—SCN11A—brain—amyotrophic lateral sclerosis	0.000636	0.00383	CbGeAlD
Zonisamide—Infection—Riluzole—amyotrophic lateral sclerosis	0.000635	0.00265	CcSEcCtD
Zonisamide—SCN1A—medulla oblongata—amyotrophic lateral sclerosis	0.000635	0.00382	CbGeAlD
Zonisamide—Shock—Riluzole—amyotrophic lateral sclerosis	0.000628	0.00263	CcSEcCtD
Zonisamide—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000626	0.00262	CcSEcCtD
Zonisamide—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000625	0.00261	CcSEcCtD
Zonisamide—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000623	0.00261	CcSEcCtD
Zonisamide—CA3—nervous system—amyotrophic lateral sclerosis	0.000623	0.00375	CbGeAlD
Zonisamide—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00062	0.00259	CcSEcCtD
Zonisamide—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000617	0.00258	CcSEcCtD
Zonisamide—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000609	0.00254	CcSEcCtD
Zonisamide—CACNA1G—brain—amyotrophic lateral sclerosis	0.000607	0.00365	CbGeAlD
Zonisamide—CA3—central nervous system—amyotrophic lateral sclerosis	0.0006	0.00361	CbGeAlD
Zonisamide—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000597	0.00249	CcSEcCtD
Zonisamide—MAOB—embryo—amyotrophic lateral sclerosis	0.000591	0.00355	CbGeAlD
Zonisamide—SCN2A—medulla oblongata—amyotrophic lateral sclerosis	0.000582	0.0035	CbGeAlD
Zonisamide—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000582	0.00243	CcSEcCtD
Zonisamide—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000578	0.00241	CcSEcCtD
Zonisamide—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000574	0.0024	CcSEcCtD
Zonisamide—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000569	0.00238	CcSEcCtD
Zonisamide—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000568	0.00237	CcSEcCtD
Zonisamide—SCN1A—spinal cord—amyotrophic lateral sclerosis	0.000566	0.0034	CbGeAlD
Zonisamide—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000562	0.00235	CcSEcCtD
Zonisamide—CA9—cerebellum—amyotrophic lateral sclerosis	0.000561	0.00338	CbGeAlD
Zonisamide—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000555	0.00232	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000551	0.0023	CcSEcCtD
Zonisamide—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000551	0.0023	CcSEcCtD
Zonisamide—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000546	0.00228	CcSEcCtD
Zonisamide—MAOB—brainstem—amyotrophic lateral sclerosis	0.000541	0.00326	CbGeAlD
Zonisamide—CA14—cerebellum—amyotrophic lateral sclerosis	0.000532	0.0032	CbGeAlD
Zonisamide—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000526	0.0022	CcSEcCtD
Zonisamide—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000522	0.00218	CcSEcCtD
Zonisamide—CA4—brainstem—amyotrophic lateral sclerosis	0.000521	0.00314	CbGeAlD
Zonisamide—CACNA1H—nervous system—amyotrophic lateral sclerosis	0.000519	0.00313	CbGeAlD
Zonisamide—SCN2A—spinal cord—amyotrophic lateral sclerosis	0.000519	0.00313	CbGeAlD
Zonisamide—CA7—brain—amyotrophic lateral sclerosis	0.000519	0.00312	CbGeAlD
Zonisamide—SCN3A—medulla oblongata—amyotrophic lateral sclerosis	0.000512	0.00308	CbGeAlD
Zonisamide—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000507	0.00212	CcSEcCtD
Zonisamide—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000505	0.00211	CcSEcCtD
Zonisamide—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000505	0.00211	CcSEcCtD
Zonisamide—MAOA—embryo—amyotrophic lateral sclerosis	0.000504	0.00303	CbGeAlD
Zonisamide—SCN4A—nervous system—amyotrophic lateral sclerosis	0.000494	0.00298	CbGeAlD
Zonisamide—CACNA1H—cerebellum—amyotrophic lateral sclerosis	0.000489	0.00294	CbGeAlD
Zonisamide—SCN1A—nervous system—amyotrophic lateral sclerosis	0.000477	0.00287	CbGeAlD
Zonisamide—CA3—brain—amyotrophic lateral sclerosis	0.000476	0.00287	CbGeAlD
Zonisamide—SCN4A—central nervous system—amyotrophic lateral sclerosis	0.000476	0.00286	CbGeAlD
Zonisamide—CA2—embryo—amyotrophic lateral sclerosis	0.000472	0.00284	CbGeAlD
Zonisamide—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000471	0.00197	CcSEcCtD
Zonisamide—MAOA—brainstem—amyotrophic lateral sclerosis	0.000462	0.00278	CbGeAlD
Zonisamide—SCN1A—central nervous system—amyotrophic lateral sclerosis	0.000459	0.00276	CbGeAlD
Zonisamide—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000458	0.00192	CcSEcCtD
Zonisamide—SCN3A—spinal cord—amyotrophic lateral sclerosis	0.000456	0.00275	CbGeAlD
Zonisamide—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000452	0.00189	CcSEcCtD
Zonisamide—SCN1A—cerebellum—amyotrophic lateral sclerosis	0.000449	0.0027	CbGeAlD
Zonisamide—CA12—nervous system—amyotrophic lateral sclerosis	0.000441	0.00265	CbGeAlD
Zonisamide—SCN2A—nervous system—amyotrophic lateral sclerosis	0.000438	0.00263	CbGeAlD
Zonisamide—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000437	0.00183	CcSEcCtD
Zonisamide—CA14—brain—amyotrophic lateral sclerosis	0.000432	0.0026	CbGeAlD
Zonisamide—CA2—brainstem—amyotrophic lateral sclerosis	0.000432	0.0026	CbGeAlD
Zonisamide—CA12—central nervous system—amyotrophic lateral sclerosis	0.000425	0.00256	CbGeAlD
Zonisamide—SCN9A—brain—amyotrophic lateral sclerosis	0.000424	0.00255	CbGeAlD
Zonisamide—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000422	0.00177	CcSEcCtD
Zonisamide—SCN2A—central nervous system—amyotrophic lateral sclerosis	0.000421	0.00254	CbGeAlD
Zonisamide—CA1—spinal cord—amyotrophic lateral sclerosis	0.000415	0.0025	CbGeAlD
Zonisamide—SCN2A—cerebellum—amyotrophic lateral sclerosis	0.000412	0.00248	CbGeAlD
Zonisamide—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000406	0.0017	CcSEcCtD
Zonisamide—Rash—Riluzole—amyotrophic lateral sclerosis	0.000403	0.00168	CcSEcCtD
Zonisamide—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000402	0.00168	CcSEcCtD
Zonisamide—Headache—Riluzole—amyotrophic lateral sclerosis	0.0004	0.00167	CcSEcCtD
Zonisamide—CACNA1H—brain—amyotrophic lateral sclerosis	0.000397	0.00239	CbGeAlD
Zonisamide—CA5B—nervous system—amyotrophic lateral sclerosis	0.000396	0.00238	CbGeAlD
Zonisamide—SCN3A—nervous system—amyotrophic lateral sclerosis	0.000385	0.00231	CbGeAlD
Zonisamide—SCN5A—nervous system—amyotrophic lateral sclerosis	0.000383	0.00231	CbGeAlD
Zonisamide—CA5B—central nervous system—amyotrophic lateral sclerosis	0.000381	0.00229	CbGeAlD
Zonisamide—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000379	0.00159	CcSEcCtD
Zonisamide—SCN4A—brain—amyotrophic lateral sclerosis	0.000378	0.00227	CbGeAlD
Zonisamide—MAOB—medulla oblongata—amyotrophic lateral sclerosis	0.000377	0.00227	CbGeAlD
Zonisamide—SCN3A—central nervous system—amyotrophic lateral sclerosis	0.00037	0.00223	CbGeAlD
Zonisamide—SCN5A—central nervous system—amyotrophic lateral sclerosis	0.000369	0.00222	CbGeAlD
Zonisamide—SCN1A—brain—amyotrophic lateral sclerosis	0.000364	0.00219	CbGeAlD
Zonisamide—CA4—medulla oblongata—amyotrophic lateral sclerosis	0.000364	0.00219	CbGeAlD
Zonisamide—SCN3A—cerebellum—amyotrophic lateral sclerosis	0.000362	0.00218	CbGeAlD
Zonisamide—CA1—nervous system—amyotrophic lateral sclerosis	0.000349	0.0021	CbGeAlD
Zonisamide—AOX1—cerebellum—amyotrophic lateral sclerosis	0.000346	0.00208	CbGeAlD
Zonisamide—CA12—brain—amyotrophic lateral sclerosis	0.000337	0.00203	CbGeAlD
Zonisamide—MAOB—spinal cord—amyotrophic lateral sclerosis	0.000337	0.00203	CbGeAlD
Zonisamide—CA1—central nervous system—amyotrophic lateral sclerosis	0.000336	0.00202	CbGeAlD
Zonisamide—SCN2A—brain—amyotrophic lateral sclerosis	0.000334	0.00201	CbGeAlD
Zonisamide—CA4—spinal cord—amyotrophic lateral sclerosis	0.000324	0.00195	CbGeAlD
Zonisamide—MAOA—medulla oblongata—amyotrophic lateral sclerosis	0.000322	0.00194	CbGeAlD
Zonisamide—CA5B—brain—amyotrophic lateral sclerosis	0.000302	0.00182	CbGeAlD
Zonisamide—CA2—medulla oblongata—amyotrophic lateral sclerosis	0.000301	0.00181	CbGeAlD
Zonisamide—SCN3A—brain—amyotrophic lateral sclerosis	0.000294	0.00177	CbGeAlD
Zonisamide—SCN5A—brain—amyotrophic lateral sclerosis	0.000293	0.00176	CbGeAlD
Zonisamide—MAOA—spinal cord—amyotrophic lateral sclerosis	0.000287	0.00173	CbGeAlD
Zonisamide—MAOB—nervous system—amyotrophic lateral sclerosis	0.000284	0.00171	CbGeAlD
Zonisamide—AOX1—brain—amyotrophic lateral sclerosis	0.000281	0.00169	CbGeAlD
Zonisamide—CA4—nervous system—amyotrophic lateral sclerosis	0.000273	0.00164	CbGeAlD
Zonisamide—MAOB—central nervous system—amyotrophic lateral sclerosis	0.000273	0.00164	CbGeAlD
Zonisamide—CA2—spinal cord—amyotrophic lateral sclerosis	0.000269	0.00162	CbGeAlD
Zonisamide—CA1—brain—amyotrophic lateral sclerosis	0.000267	0.00161	CbGeAlD
Zonisamide—MAOB—cerebellum—amyotrophic lateral sclerosis	0.000267	0.00161	CbGeAlD
Zonisamide—CA4—central nervous system—amyotrophic lateral sclerosis	0.000263	0.00158	CbGeAlD
Zonisamide—CA4—cerebellum—amyotrophic lateral sclerosis	0.000257	0.00155	CbGeAlD
Zonisamide—MAOA—nervous system—amyotrophic lateral sclerosis	0.000242	0.00146	CbGeAlD
Zonisamide—MAOA—central nervous system—amyotrophic lateral sclerosis	0.000233	0.0014	CbGeAlD
Zonisamide—MAOA—cerebellum—amyotrophic lateral sclerosis	0.000228	0.00137	CbGeAlD
Zonisamide—CA2—nervous system—amyotrophic lateral sclerosis	0.000226	0.00136	CbGeAlD
Zonisamide—CA2—central nervous system—amyotrophic lateral sclerosis	0.000218	0.00131	CbGeAlD
Zonisamide—MAOB—brain—amyotrophic lateral sclerosis	0.000217	0.0013	CbGeAlD
Zonisamide—CA2—cerebellum—amyotrophic lateral sclerosis	0.000213	0.00128	CbGeAlD
Zonisamide—CA4—brain—amyotrophic lateral sclerosis	0.000209	0.00126	CbGeAlD
Zonisamide—MAOA—brain—amyotrophic lateral sclerosis	0.000185	0.00111	CbGeAlD
Zonisamide—CA2—brain—amyotrophic lateral sclerosis	0.000173	0.00104	CbGeAlD
Zonisamide—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000146	0.000879	CbGeAlD
Zonisamide—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000141	0.000847	CbGeAlD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000113	0.00187	CbGpPWpGaD
Zonisamide—CA12—Metabolism—DAO—amyotrophic lateral sclerosis	0.000113	0.00187	CbGpPWpGaD
Zonisamide—CA13—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000112	0.00186	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000112	0.00186	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000112	0.00186	CbGpPWpGaD
Zonisamide—CA2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000109	0.00181	CbGpPWpGaD
Zonisamide—AOX1—Disease—VTA1—amyotrophic lateral sclerosis	0.000107	0.00177	CbGpPWpGaD
Zonisamide—CA4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000106	0.00175	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—MMP9—amyotrophic lateral sclerosis	0.000106	0.00175	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—MMP9—amyotrophic lateral sclerosis	0.000106	0.00175	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000105	0.00175	CbGpPWpGaD
Zonisamide—CA1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000105	0.00173	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000103	0.0017	CbGpPWpGaD
Zonisamide—CA2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000101	0.00168	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000101	0.00168	CbGpPWpGaD
Zonisamide—CA9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000101	0.00167	CbGpPWpGaD
Zonisamide—CA9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000101	0.00167	CbGpPWpGaD
Zonisamide—CA4—Metabolism—FIG4—amyotrophic lateral sclerosis	9.94e-05	0.00165	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—PFN1—amyotrophic lateral sclerosis	9.88e-05	0.00164	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PLB1—amyotrophic lateral sclerosis	9.88e-05	0.00164	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PLB1—amyotrophic lateral sclerosis	9.88e-05	0.00164	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	9.8e-05	0.00163	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—CHAT—amyotrophic lateral sclerosis	9.8e-05	0.00163	CbGpPWpGaD
Zonisamide—CA1—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.72e-05	0.00161	CbGpPWpGaD
Zonisamide—SCN4B—Developmental Biology—MMP9—amyotrophic lateral sclerosis	9.66e-05	0.0016	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—SOD1—amyotrophic lateral sclerosis	9.54e-05	0.00158	CbGpPWpGaD
Zonisamide—CA2—Metabolism—FIG4—amyotrophic lateral sclerosis	9.53e-05	0.00158	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.53e-05	0.00158	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	9.49e-05	0.00157	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	9.49e-05	0.00157	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—VAPB—amyotrophic lateral sclerosis	9.47e-05	0.00157	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—TPK1—amyotrophic lateral sclerosis	9.47e-05	0.00157	CbGpPWpGaD
Zonisamide—CA14—Metabolism—GSR—amyotrophic lateral sclerosis	9.36e-05	0.00155	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—GSTP1—amyotrophic lateral sclerosis	9.31e-05	0.00154	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PLB1—amyotrophic lateral sclerosis	9.22e-05	0.00153	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PLB1—amyotrophic lateral sclerosis	9.22e-05	0.00153	CbGpPWpGaD
Zonisamide—CA13—Metabolism—APOE—amyotrophic lateral sclerosis	9.22e-05	0.00153	CbGpPWpGaD
Zonisamide—CA9—Metabolism—VAPA—amyotrophic lateral sclerosis	9.19e-05	0.00152	CbGpPWpGaD
Zonisamide—CA1—Metabolism—FIG4—amyotrophic lateral sclerosis	9.14e-05	0.00152	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—GSR—amyotrophic lateral sclerosis	9.12e-05	0.00151	CbGpPWpGaD
Zonisamide—CA6—Metabolism—GSR—amyotrophic lateral sclerosis	9.12e-05	0.00151	CbGpPWpGaD
Zonisamide—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.07e-05	0.0015	CbGpPWpGaD
Zonisamide—CA4—Metabolism—DAO—amyotrophic lateral sclerosis	8.99e-05	0.00149	CbGpPWpGaD
Zonisamide—SCN3B—Developmental Biology—MMP9—amyotrophic lateral sclerosis	8.98e-05	0.00149	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—FIG4—amyotrophic lateral sclerosis	8.96e-05	0.00149	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	8.74e-05	0.00145	CbGpPWpGaD
Zonisamide—SCN4B—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	8.68e-05	0.00144	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—VAPA—amyotrophic lateral sclerosis	8.66e-05	0.00144	CbGpPWpGaD
Zonisamide—CA2—Metabolism—DAO—amyotrophic lateral sclerosis	8.62e-05	0.00143	CbGpPWpGaD
Zonisamide—CA9—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.55e-05	0.00142	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PLB1—amyotrophic lateral sclerosis	8.55e-05	0.00142	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—GSR—amyotrophic lateral sclerosis	8.51e-05	0.00141	CbGpPWpGaD
Zonisamide—CA7—Metabolism—GSR—amyotrophic lateral sclerosis	8.51e-05	0.00141	CbGpPWpGaD
Zonisamide—CA1—Metabolism—DAO—amyotrophic lateral sclerosis	8.27e-05	0.00137	CbGpPWpGaD
Zonisamide—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	8.2e-05	0.00136	CbGpPWpGaD
Zonisamide—AOX1—Disease—CHMP2B—amyotrophic lateral sclerosis	8.11e-05	0.00134	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—DAO—amyotrophic lateral sclerosis	8.11e-05	0.00134	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	8.07e-05	0.00134	CbGpPWpGaD
Zonisamide—SCN3B—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	8.07e-05	0.00134	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.05e-05	0.00134	CbGpPWpGaD
Zonisamide—CA9—Metabolism—FIG4—amyotrophic lateral sclerosis	8.03e-05	0.00133	CbGpPWpGaD
Zonisamide—CA12—Metabolism—GSR—amyotrophic lateral sclerosis	7.89e-05	0.00131	CbGpPWpGaD
Zonisamide—MAOA—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.76e-05	0.00129	CbGpPWpGaD
Zonisamide—CA14—Metabolism—CHAT—amyotrophic lateral sclerosis	7.68e-05	0.00127	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—FIG4—amyotrophic lateral sclerosis	7.57e-05	0.00126	CbGpPWpGaD
Zonisamide—CA6—Metabolism—CHAT—amyotrophic lateral sclerosis	7.49e-05	0.00124	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—CHAT—amyotrophic lateral sclerosis	7.49e-05	0.00124	CbGpPWpGaD
Zonisamide—AOX1—Disease—PLB1—amyotrophic lateral sclerosis	7.34e-05	0.00122	CbGpPWpGaD
Zonisamide—CA9—Metabolism—DAO—amyotrophic lateral sclerosis	7.27e-05	0.0012	CbGpPWpGaD
Zonisamide—CA7—Metabolism—CHAT—amyotrophic lateral sclerosis	6.99e-05	0.00116	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—CHAT—amyotrophic lateral sclerosis	6.99e-05	0.00116	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—DAO—amyotrophic lateral sclerosis	6.85e-05	0.00114	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PLB1—amyotrophic lateral sclerosis	6.81e-05	0.00113	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—MMP9—amyotrophic lateral sclerosis	6.8e-05	0.00113	CbGpPWpGaD
Zonisamide—AOX1—Disease—VCP—amyotrophic lateral sclerosis	6.54e-05	0.00108	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PLB1—amyotrophic lateral sclerosis	6.53e-05	0.00108	CbGpPWpGaD
Zonisamide—CA12—Metabolism—CHAT—amyotrophic lateral sclerosis	6.48e-05	0.00107	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—MMP9—amyotrophic lateral sclerosis	6.44e-05	0.00107	CbGpPWpGaD
Zonisamide—CA3—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.41e-05	0.00106	CbGpPWpGaD
Zonisamide—CA13—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.32e-05	0.00105	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	6.32e-05	0.00105	CbGpPWpGaD
Zonisamide—CA4—Metabolism—GSR—amyotrophic lateral sclerosis	6.29e-05	0.00104	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PLB1—amyotrophic lateral sclerosis	6.26e-05	0.00104	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PLB1—amyotrophic lateral sclerosis	6.14e-05	0.00102	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—VEGFA—amyotrophic lateral sclerosis	6.1e-05	0.00101	CbGpPWpGaD
Zonisamide—CA2—Metabolism—GSR—amyotrophic lateral sclerosis	6.03e-05	0.001	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—TPK1—amyotrophic lateral sclerosis	5.94e-05	0.000986	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—VAPB—amyotrophic lateral sclerosis	5.94e-05	0.000986	CbGpPWpGaD
Zonisamide—CA3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.89e-05	0.000976	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—VEGFA—amyotrophic lateral sclerosis	5.79e-05	0.000959	CbGpPWpGaD
Zonisamide—CA1—Metabolism—GSR—amyotrophic lateral sclerosis	5.78e-05	0.000958	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	5.78e-05	0.000958	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—GSR—amyotrophic lateral sclerosis	5.67e-05	0.00094	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	5.64e-05	0.000935	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PLB1—amyotrophic lateral sclerosis	5.51e-05	0.000913	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—VAPA—amyotrophic lateral sclerosis	5.44e-05	0.000901	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	5.37e-05	0.000891	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PLB1—amyotrophic lateral sclerosis	5.19e-05	0.000861	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CHAT—amyotrophic lateral sclerosis	5.16e-05	0.000856	CbGpPWpGaD
Zonisamide—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	5.11e-05	0.000847	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GSR—amyotrophic lateral sclerosis	5.08e-05	0.000843	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.05e-05	0.000838	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	5.05e-05	0.000837	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—MMP9—amyotrophic lateral sclerosis	5.01e-05	0.000831	CbGpPWpGaD
Zonisamide—CA2—Metabolism—CHAT—amyotrophic lateral sclerosis	4.95e-05	0.000821	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	4.93e-05	0.000818	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—MMP9—amyotrophic lateral sclerosis	4.85e-05	0.000805	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—MMP9—amyotrophic lateral sclerosis	4.85e-05	0.000804	CbGpPWpGaD
Zonisamide—CA3—Metabolism—APOE—amyotrophic lateral sclerosis	4.85e-05	0.000803	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GSR—amyotrophic lateral sclerosis	4.79e-05	0.000794	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	4.78e-05	0.000793	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—MMP9—amyotrophic lateral sclerosis	4.77e-05	0.00079	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—FIG4—amyotrophic lateral sclerosis	4.75e-05	0.000788	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CHAT—amyotrophic lateral sclerosis	4.75e-05	0.000787	CbGpPWpGaD
Zonisamide—AOX1—Disease—CST3—amyotrophic lateral sclerosis	4.69e-05	0.000778	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CHAT—amyotrophic lateral sclerosis	4.66e-05	0.000772	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	4.6e-05	0.000762	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—MMP9—amyotrophic lateral sclerosis	4.56e-05	0.000756	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—VEGFA—amyotrophic lateral sclerosis	4.5e-05	0.000746	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—MMP9—amyotrophic lateral sclerosis	4.38e-05	0.000726	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—MMP9—amyotrophic lateral sclerosis	4.38e-05	0.000726	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—VEGFA—amyotrophic lateral sclerosis	4.36e-05	0.000723	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	4.36e-05	0.000722	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—DAO—amyotrophic lateral sclerosis	4.3e-05	0.000713	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—VEGFA—amyotrophic lateral sclerosis	4.28e-05	0.00071	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—MMP9—amyotrophic lateral sclerosis	4.22e-05	0.0007	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CHAT—amyotrophic lateral sclerosis	4.17e-05	0.000692	CbGpPWpGaD
Zonisamide—CA14—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.13e-05	0.000685	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	4.13e-05	0.000685	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—VEGFA—amyotrophic lateral sclerosis	4.09e-05	0.000679	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	4.03e-05	0.000669	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.02e-05	0.000667	CbGpPWpGaD
Zonisamide—CA6—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.02e-05	0.000667	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CHAT—amyotrophic lateral sclerosis	3.93e-05	0.000652	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—VEGFA—amyotrophic lateral sclerosis	3.93e-05	0.000652	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—VEGFA—amyotrophic lateral sclerosis	3.93e-05	0.000652	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—VEGFA—amyotrophic lateral sclerosis	3.8e-05	0.00063	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.8e-05	0.000629	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—VEGFA—amyotrophic lateral sclerosis	3.79e-05	0.000629	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.76e-05	0.000623	CbGpPWpGaD
Zonisamide—CA7—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.76e-05	0.000623	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.7e-05	0.000613	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.7e-05	0.000613	CbGpPWpGaD
Zonisamide—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.67e-05	0.000609	CbGpPWpGaD
Zonisamide—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.62e-05	0.0006	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—MMP9—amyotrophic lateral sclerosis	3.58e-05	0.000593	CbGpPWpGaD
Zonisamide—CA12—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.48e-05	0.000577	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—MMP9—amyotrophic lateral sclerosis	3.46e-05	0.000574	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.46e-05	0.000574	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.45e-05	0.000572	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.45e-05	0.000572	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	3.42e-05	0.000567	CbGpPWpGaD
Zonisamide—AOX1—Disease—CASP9—amyotrophic lateral sclerosis	3.41e-05	0.000566	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	3.4e-05	0.000564	CbGpPWpGaD
Zonisamide—CA3—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.32e-05	0.00055	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PLB1—amyotrophic lateral sclerosis	3.26e-05	0.00054	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	3.25e-05	0.000539	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	3.21e-05	0.000532	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.2e-05	0.00053	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	3.13e-05	0.000518	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	3.13e-05	0.000518	CbGpPWpGaD
Zonisamide—CA14—Metabolism—APOE—amyotrophic lateral sclerosis	3.12e-05	0.000518	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	3.11e-05	0.000516	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	3.05e-05	0.000506	CbGpPWpGaD
Zonisamide—CA6—Metabolism—APOE—amyotrophic lateral sclerosis	3.04e-05	0.000504	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—APOE—amyotrophic lateral sclerosis	3.04e-05	0.000504	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	3.01e-05	0.0005	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSR—amyotrophic lateral sclerosis	3.01e-05	0.000498	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—MMP9—amyotrophic lateral sclerosis	2.97e-05	0.000492	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	2.92e-05	0.000484	CbGpPWpGaD
Zonisamide—AOX1—Disease—ERBB4—amyotrophic lateral sclerosis	2.92e-05	0.000484	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	2.87e-05	0.000476	CbGpPWpGaD
Zonisamide—CA7—Metabolism—APOE—amyotrophic lateral sclerosis	2.84e-05	0.000471	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—APOE—amyotrophic lateral sclerosis	2.84e-05	0.000471	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	2.81e-05	0.000466	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	2.81e-05	0.000466	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	2.81e-05	0.000465	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	2.81e-05	0.000465	CbGpPWpGaD
Zonisamide—CA4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.78e-05	0.00046	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	2.71e-05	0.000449	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—VEGFA—amyotrophic lateral sclerosis	2.67e-05	0.000442	CbGpPWpGaD
Zonisamide—CA2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.66e-05	0.000441	CbGpPWpGaD
Zonisamide—CA12—Metabolism—APOE—amyotrophic lateral sclerosis	2.63e-05	0.000436	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.62e-05	0.000435	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	2.57e-05	0.000427	CbGpPWpGaD
Zonisamide—CA1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.55e-05	0.000423	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.55e-05	0.000423	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.5e-05	0.000415	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CHAT—amyotrophic lateral sclerosis	2.47e-05	0.000409	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.45e-05	0.000405	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.39e-05	0.000397	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.34e-05	0.000389	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.3e-05	0.000381	CbGpPWpGaD
Zonisamide—AOX1—Disease—APOE—amyotrophic lateral sclerosis	2.26e-05	0.000375	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	2.25e-05	0.000373	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.24e-05	0.000372	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.21e-05	0.000366	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.18e-05	0.000361	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.14e-05	0.000355	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	2.12e-05	0.000351	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.11e-05	0.000351	CbGpPWpGaD
Zonisamide—CA4—Metabolism—APOE—amyotrophic lateral sclerosis	2.1e-05	0.000348	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.08e-05	0.000346	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.08e-05	0.000346	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.06e-05	0.000342	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	2.03e-05	0.000337	CbGpPWpGaD
Zonisamide—CA2—Metabolism—APOE—amyotrophic lateral sclerosis	2.01e-05	0.000334	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.95e-05	0.000323	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.95e-05	0.000323	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.94e-05	0.000322	CbGpPWpGaD
Zonisamide—CA1—Metabolism—APOE—amyotrophic lateral sclerosis	1.93e-05	0.00032	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	1.9e-05	0.000315	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—APOE—amyotrophic lateral sclerosis	1.89e-05	0.000314	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.8e-05	0.000299	CbGpPWpGaD
Zonisamide—CA9—Metabolism—APOE—amyotrophic lateral sclerosis	1.7e-05	0.000281	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.69e-05	0.000281	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.69e-05	0.000281	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—APOE—amyotrophic lateral sclerosis	1.6e-05	0.000265	CbGpPWpGaD
Zonisamide—AOX1—Disease—PTGS2—amyotrophic lateral sclerosis	1.55e-05	0.000257	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.55e-05	0.000257	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.54e-05	0.000256	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.44e-05	0.000239	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.44e-05	0.000238	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.42e-05	0.000236	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.38e-05	0.000229	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.35e-05	0.000224	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.33e-05	0.00022	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.32e-05	0.000219	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.3e-05	0.000215	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.3e-05	0.000215	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.22e-05	0.000203	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.22e-05	0.000202	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	1.17e-05	0.000194	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.16e-05	0.000193	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.1e-05	0.000182	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.07e-05	0.000177	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—APOE—amyotrophic lateral sclerosis	1e-05	0.000166	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	9.27e-06	0.000154	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	8.56e-06	0.000142	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.3e-06	0.000121	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	7.03e-06	0.000116	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.87e-06	0.000114	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.28e-06	0.000104	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.77e-06	9.57e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	4.75e-06	7.87e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.78e-06	6.26e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.47e-06	5.75e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.25e-06	5.39e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.85e-06	4.73e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.96e-06	3.24e-05	CbGpPWpGaD
